Elevated Levels of Homocysteine Predict Cardiovascular Death, Nonfatal Myocardial Infarction, and Symptomatic Bypass Graft Disease at 2-Year Follow-Up Following Coronary Artery Bypass Surgery
| Autor: | Eric J. Dippel, Mythri Reddy, Michael Jerin, Nicolas W. Shammas, Harb Harb, Matthew J Kapalis, Peter P. Toth |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
medicine.medical_specialty Statin Homocysteine medicine.drug_class Myocardial Infarction Coronary Artery Disease Coronary artery disease Coronary artery bypass surgery chemistry.chemical_compound Predictive Value of Tests Internal medicine Humans Medicine Myocardial infarction Coronary Artery Bypass Aged Univariate analysis Aspirin Ejection fraction business.industry Graft Occlusion Vascular Public Health Environmental and Occupational Health Middle Aged medicine.disease Treatment Outcome chemistry Cardiology Female Cardiology and Cardiovascular Medicine business Follow-Up Studies medicine.drug |
| Zdroj: | Preventive Cardiology. 11:95-99 |
| ISSN: | 1520-037X |
| DOI: | 10.1111/j.1751-7141.2008.08293.x |
| Popis: | Severe graft disease occurs in patients at a rate of approximately 15% within the first year of coronary artery bypass grafting (CABG). In this study, the authors examined predictors of the combined end point of death, nonfatal myocardial infarction (MI), and bypass graft disease at 2-year follow-up after CABG. One hundred twenty-one consecutive patients were included in this study after informed consent was obtained. In univariate analysis, there was a significantly (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text